Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating IBI363 as neoadjuvant therapy for resectable stage II-III non-small cell lung cancer is listed, with status not y…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer [Phase 2]
A prospective Phase II study evaluating immunotherapy combined with chemotherapy for stage III unresectable non-small cell lung cancer is cu…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating adjuvant chemotherapy with or without cemiplimab and sequential hypofractionated radiotherapy in…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update evaluating sacituzumab govitecan combinations as first-line therapy for advanced or metastatic non-small cell lung canc…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC [Phase 1]
Phase 1 trial of novel anti-cancer agents in patients with metastatic non-small cell lung cancer; the study is active but not currently recr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of MCLA-129, a bispecific EGFR and cMet antibody, in advanced non-small cell lung cancer and other solid tumors, currently r…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels [Phase 2]
A Phase 2 trial is evaluating immunotherapy without chemotherapy for advanced non-small cell lung cancer with high PD-L1 expression; the stu…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC [Phase 2]
A Phase II clinical trial recruiting to evaluate postoperative radiotherapy after neoadjuvant chemo-immunotherapy and surgery in stage III n…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E) [Phase 2]
ADAPT-E is a Phase 2 clinical trial evaluating adjuvant ctDNA–guided, personalized treatment for early-stage non-small cell lung cancer and …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positvie ctDNA After lead-in Osimertinib Monotherapy [Phase 2]
A Phase II ctDNA-guided trial evaluating the combination of osimertinib with sacituzumab govitecan in EGFR-mutated advanced non-small cell l…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Anlotinib in Cross-line Treatment of NSCLC and SCLC
This clinical trial update shows that anlotinib is being evaluated for cross-line treatment of advanced non-small cell lung cancer and exten…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
This clinical trial update analyzes clinical outcomes and genomic data from American Indian patients across several cancer indications, with…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Complications Associated With Lymphadenectomy (LAD) in Surgical Treatment of Non-small Cell Lung Cancer (NSCLC). [NA]
An ongoing clinical trial is examining complications associated with lymphadenectomy in the surgical treatment of advanced non-small cell lu…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated With Immunotherapy and Chemotherapy in the Maintenance Phase [NA]
This clinical trial examines whether respiratory rehabilitation improves quality of life for patients with metastatic non-small cell lung ca…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2 [Phase 1]
A Phase 1 clinical trial is investigating pembrolizumab in combination with a single-agent chemotherapy as first-line treatment for locally …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial update of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy, being studied in advanced or metastatic solid tumors. The study is …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
A prospective cohort study evaluating Zorifertinib as first-line therapy for EGFR-mutant advanced non-small cell lung cancer with brain/CNS …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Neoadjuvant Lazertinib With or Without Chemotherapy for Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer [Phase 2]
This clinical trial update describes a Phase 2 neoadjuvant study of lazertinib, with or without chemotherapy, in patients with EGFR-mutated …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC [Phase 1]
Phase 1 trial investigating ceritinib in combination with docetaxel for ALK-negative, EGFR wild-type advanced non-small cell lung cancer; th…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating risk-adapted, proteomic-guided systemic therapy for previously untreated, advanced non-small cell lung can…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC [Phase 2]
Phase 2 clinical trial evaluating the combination of immunotherapy, chemotherapy, radiotherapy, and surgery for patients with synchronous ol…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT) [Phase 2]
Phase 2 BEAT trial compares atezolizumab alone versus atezolizumab plus bevacizumab as first-line therapy in non-small cell lung cancer; the…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
A clinical trial at Abramson Cancer Center investigates the effects of immune checkpoint inhibitors on the coronary microvasculature, with a…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases [Phase 2]
Phase 2 trial update on the efficacy and safety of trastuzumab deruxtecan (Enhertu) in HER2-mutant advanced non-small cell lung cancer, incl…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: GCC 2546- Motion Management [NA]
Clinical trial entry GCC 2546- Motion Management is not yet recruiting for non-small cell lung cancer, with radiation as part of the conditi…